[1]
Molnár, T., Farkas, K., Nyári, T., Szepes, Z., Nagy, F. and Wittmann, T. 2012. Frequency and Predictors of loss of Response to Infliximab or Adalimumab in Crohn’s Disease after One-Year Treatment Period – A Single Center Experience. Journal of Gastrointestinal and Liver Diseases. 21, 3 (Sep. 2012), 265–269.